Endogenous Human SMN1 Promoter-driven Gene Replacement Improves the Efficacy and Safety of AAV9-mediated Gene Therapy for SMA in mice

被引：0
|
作者：
Xie, J. [1 ]
Xie, Q. [1 ]
Ma, H. [1 ]
Chen, X. [1 ]
Zhu, Y. [2 ]
Ma, Y. [2 ]
Jalinous, L. [2 ]
Su, Q. [1 ]
Tai, P. [1 ]
Gao, G. [1 ]
机构：
[1] Umass Chan Med Sch, Gene Therapy Ctr, Worcester, MA USA
[2] CANbridge Pharmaceut, Cambridge, MA USA
来源：
NEUROMUSCULAR DISORDERS | 2022年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
LSVP.05
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Treatment of SMA type 1 infants using a single-dose AAV9-mediated gene therapy via intrathecal injection of GC101: An open-label, single-arm study
    Ma, Xiuwei
    Zhuang, Lu
    Ma, Wenhao
    Li, Jun
    Wang, Xiaodong
    Li, Zhongqiu
    Jiang, Xinyang
    Wang, Yongxia
    Du, Ying
    Zhang, Yingqian
    He, Fang
    Zhu, Zhiming
    Du, Shaopeng
    Xu, Juan
    Gu, Ruijie
    Zhang, Yanping
    Zhang, Shan
    Li, Ting
    Yang, Xiao
    Zhang, Sheng
    Zhu, Lina
    Li, Qiuping
    Dong, Xiaoyan
    Wu, Xiaobing
    Feng, Zhichun
    CHINESE MEDICAL JOURNAL, 2024, 137 (16) : 1976 - 1978
  • [32] ICV Delivery of AAV9-NGLY1 Gene Replacement Therapy Improves Phenotypic and Biomarker Endpoints in Ngly1 Deficient Rats
    Zhu, Lei
    Tan, Brandon
    Crawford, Brett
    Dwight, Selina
    Beahm, Brendan
    Wilsey, Matt
    Wechsler, Thomas
    Mueller, William
    MOLECULAR THERAPY, 2021, 29 (04) : 277 - 277
  • [33] Generation of Endogenous Promoter-Driven Luciferase Reporter System Using CRISPR/Cas9 for Investigating Transcriptional Regulation of the Core Clock Gene BMAL1
    Sun, Chengxi
    Li, Chen
    Liu, Wen
    Schioth, Helgi B.
    BIOMEDICINES, 2022, 10 (12)
  • [34] Systemic AAV9 gene therapy improves the lifespan of mice with Niemann-Pick disease, type C1
    Chandler, Randy J.
    Williams, Ian M.
    Gibson, Alana L.
    Davidson, Cristin D.
    Incao, Arturo A.
    Hubbard, Brandon T.
    Porter, Forbes D.
    Pavan, William J.
    Venditti, Charles P.
    HUMAN MOLECULAR GENETICS, 2017, 26 (01) : 52 - 64
  • [35] Clinical Safety and Efficacy of EXG001-307 in SMA Type 1 Patients: A Next-Generation AAV-Based Gene Therapy
    Wu, Zhenhua
    Song, Chunjuan
    Li, Wenhui
    Li, Xiaojing
    Zhu, Xiaomei
    Li, Hui
    Yang, Meijia
    Yang, Wenshu
    Ji, Rui
    Lu, Kuan
    Zhang, Yanna
    Li, Haifeng
    Wang, Lijun
    Ye, Guo-jie
    Shu, Qiang
    Wang, Yi
    MOLECULAR THERAPY, 2024, 32 (04) : 320 - 320
  • [36] Preclinical evaluation of AAV9-coSMN1 gene therapy for spinal muscular atrophy: efficacy and safety in mouse models and non-human primates
    Wenhao Ma
    Zhijie Wu
    Tianyi Zhao
    Yan Xia
    Jing Qin
    Xue Tian
    Xin Li
    Jun He
    Yan Zhang
    Lina Zhang
    Li Li
    Zheyue Dong
    Zhichun Feng
    Xiaoyan Dong
    Wang Sheng
    Xiaobing Wu
    Molecular Medicine, 31 (1)
  • [37] Comparison of long-term survival of cytomegalovirus promoter versus Rous Sarcoma virus promoter-driven thymidine kinase gene therapy in nude mice bearing human ovarian cancer
    Tong, XW
    Engehausen, DG
    Freund, CTF
    Agoulnik, I
    Oehler, MK
    Kim, TE
    Hasenburg, A
    Guo, ZS
    Contant, CF
    Woo, SLC
    Kieback, DG
    HYBRIDOMA, 1999, 18 (01): : 93 - 97
  • [38] AAV-Mediated Lysophosphatidylcholine Acyltransferase 1 (Lpcat1) Gene Replacement Therapy Rescues Retinal Degeneration in rd11 Mice
    Dai, Xufeng
    Han, Juanjuan
    Qi, Yan
    Zhang, Hua
    Xiang, Lue
    Lv, Jineng
    Li, Jie
    Deng, Wen-Tao
    Chang, Bo
    Hauswirth, William W.
    Pang, Ji-jing
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (03) : 1724 - 1734
  • [39] Human GLB1 knockout cerebral organoids: A model system for testing AAV9-mediated GLB1 gene therapy for reducing GM1 ganglioside storage in GM1 gangliosidosis
    Latour, Yvonne L.
    Yoon, Robin
    Thomas, Sarah E.
    Grant, Christina
    Li, Cuiling
    Sena-Esteves, Miguel
    Allende, Maria L.
    Proia, Richard L.
    Tifft, Cynthia J.
    MOLECULAR GENETICS AND METABOLISM REPORTS, 2019, 21
  • [40] AAV-Mediated sFLT-1 Gene Therapy for Ocular Neovascularization: Longevity, Toxicity and Efficacy Results from Mice and Monkeys
    Rakoczy, E. P.
    Lai, C. M.
    Shen, W. Y.
    Brankov, M.
    Barnett, N.
    Lee, S. Y.
    Leaver, S. G.
    Yeo, I.
    Ang, C. L.
    Constable, I. J.
    MOLECULAR THERAPY, 2006, 13 : S160 - S161
12345